<DOC>
	<DOC>NCT00689598</DOC>
	<brief_summary>To determine whether or not spironolactone can prevent or delay the occurrence of atrial fibrillation.</brief_summary>
	<brief_title>Spironolactone for Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>To determine whether or not adding spironolactone can prevent or delay the occurrence of paroxysmal atrial fibrillation in patients who have received propafenone treatment.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Inclusion criteria: 1. 18 to 80 Y/O, 2. Paroxysmal AF. Exclusion criteria: 1. GPT&gt;100 IU/L or tota bilirubin &gt;2 mg/dl; 2. Creatinine &gt; 2 mg/dl; 3. Serum potassium &gt;= 5 mM; 4. Serum sodium &lt;=130 mM; 5. Uric acid &gt; 10 mg/dlã€‚</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Atrial fibrillation, spironolactone</keyword>
</DOC>